“
“Objective: The aim of this study was to evaluate the effectiveness selleckchem and safety of percutaneous interstitial implantation with I-125 seed under computed tomographic (CT) guidance for recurrent ovarian cancer (ROC). Materials and Methods: A retrospective review

was performed on 17 patients with ROC who were treated with I-125 seed brachytherapy. Treatment planning system was used preoperatively to determine the estimated seeds number and distribution; I-125 seeds were implanted into recurrent lesions under CT guidance. Therapeutic effectiveness and complications were noted during follow-up time. Results: Months are counted from the time of I-125 seed brachytherapy, and the median duration of follow-up was 10.5 months (3-23 months). The objective response rates after 1,

3, 6, 12, and 18 months were 76.5%, 75.0%, 61.5%, 42.9%, and 40%, respectively. The pain relief rate was 61.5%, and the general living quality was improved dramatically. The median progression-free survival time was 5.4 months, the median overall survival time was 11.3 months, and the 1-year survival rate was 41.2%. Complications in this study were very mild; severe adverse events such as massive bleeding, intestinal fistula, and treatment-related deaths did not occur. Conclusions: Our initial experience showed that CT-guided I-125 seed interstitial implantation is safe and feasible in the treatment of patients with ROCs after multiple therapies.”
“The

number of resting follicles in the ovary and their successful maturation during development define the fertile female lifespan. Oocytes, enclosed within find more LB-100 clinical trial follicles, are subject to natural selection, and the majority will undergo apoptosis during prenatal life through adulthood. Our previous studies revealed high levels of the lipid hydrolase, acid ceramidase (AC), in human and mouse oocytes, follicular fluid and cumulus cells. In addition, supplementation of in vitro fertilization media with recombinant AC enhanced the survival of oocytes and preimplantation embryos. Herein we constructed and used a conditional knockout mouse model of AC deficiency (cACKO) to further investigate the role of this enzyme in oocyte survival in vivo. Immunohistochemical staining, activity assays, and western blot analysis revealed that AC expression was high in the ovaries of normal mice, particularly in the theca cells. After induction of the AC gene knockout with tamoxifen (TM), AC levels decreased in ovaries, and ceramide was correspondingly elevated. A novel immunostaining method was developed to visualize follicles at various stages, and together with light microscopic examination, the transition of the follicle from the secondary to antral stage was found to be defective in the absence of AC. Western blot analysis showed elevated BAX and PARP expression in TM-treated cACKO mouse ovaries compared to control animals.